* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Concord Medical Services Holdings Buyback Yield % Chart
FRA:C2C vs CCEL, GBCS, CDIX: Buyback Yield % Comparison
For the Medical Care Facilities subindustry, Concord Medical Services Holdings's Buyback Yield %, along with its competitors' market caps and Buyback Yield % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Concord Medical Services Holdings Buyback Yield % vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Concord Medical Services Holdings's Buyback Yield % distribution charts can be found below:
* The bar in red indicates where Concord Medical Services Holdings's Buyback Yield % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Concord Medical Services Holdings (FRA:C2C) has a Buyback Yield % of 0.00 as of Jul. 07, 2026. Share buyback yield equals the net issuance of stock divided by market cap. View historical data on Concord Medical Services Holdings and its competitors. According to the industry distribution chart, Concord Medical Services Holdings ranks #999999 out of 275 companies in the Healthcare Providers & Services industry.
Is Concord Medical Services Holdings' Buyback Yield % too high?
Concord Medical Services Holdings' current Buyback Yield % is 0.00. Based on the distribution chart, Concord Medical Services Holdings ranks #999999 out of 275 companies in the Healthcare Providers & Services industry, which is in the bottom quartile relative to peers. Overall, Concord Medical Services Holdings has a GF Score™ of 52/100, reflecting its overall financial health beyond just this single metric.
How does Concord Medical Services Holdings' Buyback Yield % compare to CCEL and GBCS?
According to the Healthcare Providers & Services industry distribution chart, Concord Medical Services Holdings ranks #999999 out of 275 companies for Buyback Yield %. This places Concord Medical Services Holdings in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Buyback Yield % for a Healthcare Providers & Services company?
A good Buyback Yield % depends on the Healthcare Providers & Services industry context. However, Buyback Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Buyback Yield % mean?
A high Buyback Yield % can signal that a stock is expensive relative to its fundamentals. Share buyback yield equals the net issuance of stock divided by market cap. View historical data on Concord Medical Services Holdings and its competitors. Concord Medical Services Holdings's current Buyback Yield % is 0.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Concord Medical Services Holdings stock overvalued right now?
Concord Medical Services Holdings (FRA:C2C) has a current Buyback Yield % of 0.00. The stock's GF Value™ is €9.20, compared to a current price of €6.25 — trading 32.1% below its estimated fair value. The current Buyback Yield % is 0.00. Concord Medical Services Holdings' overall GF Score™ is 52/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Buyback Yield % calculated?
Buyback Yield % is calculated from a company's financial statements. For Concord Medical Services Holdings (FRA:C2C), the current Buyback Yield % is 0.00 as of Jul. 07, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Concord Medical Services Holdings (FRA:C2C) Overvalued in 2026?
Based on GuruFocus' analysis, Concord Medical Services Holdings stock appears to be undervalued.
The current stock price of €6.25 is trading 32.1% below its estimated GF Value™ of €9.20.
Key valuation signals for FRA:C2C:
Buyback Yield %: 0.00
GF Value™: €9.20 vs. price of €6.25 (32.1% below fair value)
No single metric tells the full story. See the FRA:C2C stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Concord Medical Services Holdings Business Description
Concord Medical Services Holdings Ltd operates radiotherapy and diagnostic imaging centers in China. The company is involved in the leasing of radiotherapy and diagnostic imaging equipment, provision of management services to hospitals, medicine sales, and provision of premium cancer and proton treatment services. The company has two operating segments, including network and hospital. Geographically, the company derives revenue from PRC.
52GF Score
Get the complete analysis for FRA:C2C
Buyback Yield % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FRA:C2C has been successfully added to your 
